chartexchange

Odyssey Therapeutics, Inc. (ODTX) Discusses Additional Phase IIa Data for OD-001 in Ulcerative Colitis from UEG Week Presentation Transcript

Seeking Alpha | Oct 20, 2026 3:14 PM EDT

Read original article